Platforms

Orionis has developed multiple technology platforms for the discovery of new generations of therapeutics and precision medicines whose pharmacological activities are directed by design to disease targets, avoiding undesired off-target interactions and potentially associated drug liabilities. Our technology platforms further enable access to a broad range of target types to address multiple key disease vulnerabilities for the development of novel therapies.